Destiny Pharma PLC undervalued compared to peers, suggests finnCap
"Phase 3 trial design is due to be finalised in H1 2022, which should catalyse partnering discussions.“ Destiny Pharma’s 29021...
pharma
Destiny Pharma PLC (AIM:DEST) presenting at the Proactive One2One Virtual Forum
Destiny Pharma PLC (AIM:DEST) presenting at the Proactive One2One Virtual Forum - 17th March 2022 Destiny Pharma PLC (AIM:DEST) (Destiny...
Destiny Pharma PLC unveils further positive results for c-difficile treatment as market research points to its commercial potential
NTCD-M3, which researchers are readying to phase III clinical trials, was the subject to a separate preclinical study by the...
Pharma shares trade firm; Laurus up 2%, Sun Pharma nears 52-week high
Shares of pharmaceutical companies were trading firm in an otherwise subdued market, with Nifty Pharma index gaining nearly...
MARKETS: MARKETS: Sensex, Nifty exhibit volatility; pharma firm, IT weakens
Markets at 10 amLIVE market updates: The benchmark indices continued to inch up and held onto mild...
Destiny Pharma – Neil Clark, CEO (AIM:DEST) One2One Virtual Forum 10th December 2021
Destiny Pharma PLC (AIM:DEST) (Destiny Pharma PLC (AIM:DEST)) is a clinical stage, innovative biotechnology company focused on the development of...
MARKETS: Sensex, Nifty volatile; FMCG, pharma rally, banks fall
Opening Bell LIVE market updates: Market bulls roared on Dalal Street for third straight day on Thursday amid...
Stocks to Watch: Reliance, ITC, Paytm, BoB, FMCG, pharma, airline stocks
The markets are likely to attempt a pull-back in early trade this morning following Friday's sell-off as indicated...
Destiny Pharma PLC looks to build on the progress made with its two key assets
The company is blazing a trail in the infection arena and reckons it has two potential blockbuster treatments on its...
Destiny Pharma PLC teams up with US Department of Veterans Affairs to find ‘new attributes’ for its next-generation antibiotic
NTCD-M3 is being developed to combat Clostridioides difficile infections (CDI) in the gut () said it is teaming up with...
